Topical delivery of caffeine from some commercial formulations

International Journal of Pharmaceutics

Volumn 182, Issue 1, 1999, Pages 41-47

  Dias, M ^b   Farinha, A ^a   Faustino, E ^c   Hadgraft, J ^b   Pais, J ^a   Toscano, C ^a  

^a Lab de Estud Famaceuticos (LEF)   (Portugal)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c Famatra Sociedade Farmaceut SA   (Portugal)

Author keywords

Caffeine; Formulation effects; Percutaneous absorption; Topical delivery

Indexed keywords

CAFFEINE; CELLACTIA; CELLULOSE ACETATE; ELANCYL; MYRISTIC ACID ISOPROPYL ESTER; SILASTIC; SOMMA; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DRUG FORMULATION; HUMAN; HUMAN TISSUE; MEMBRANE PERMEABILITY; MEMBRANE TRANSPORT; PRIORITY JOURNAL; SKIN ABSORPTION; SKIN PENETRATION; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; CAFFEINE; CELLULOSE; CENTRAL NERVOUS SYSTEM STIMULANTS; CHEMISTRY, PHARMACEUTICAL; DIFFUSION; HUMANS; KINETICS; MEMBRANES, ARTIFICIAL; PERMEABILITY; SILICON; SKIN; SKIN ABSORPTION; SOLUBILITY; SOLUTIONS;

EID: 0032895510     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(99)00067-8     Document Type: Article

References (5)

1. Albery W.J., Hadgraft J. Percutaneous adsorption: in vivo experiments. J. Pharm. Pharmacol. 31:1979;140-147.
2. Guy R.H., Hadgraft J. On the determination of drug release rates from topical dosage forms. Int. J. Pharm. 60:1990;R1-R3.
3. Potts R.O., Francoeur M.L. The influence of stratum corneum morphology on water permeability. J. Invest. Dermatol. 96:1991;495-499.
4. Potts R.O., Guy R.H. Predicting skin permeability. Pharm. Res. 9:1992;663-669.
5. Roberts M.S., Pugh W.J., Hadgraft J. Epidermal permeability-penetrant structure relationships. 2. The effect of H-bonding groups in penetrants on their diffusion through the stratum corneum. Int. J. Pharm. 132:1996;23-42.